Selection of a mineralocorticoid receptor antagonist for patients with hypertension or heart failure

Publisher： John Wiley & Sons Inc

E-ISSN： 1879-0844|16|2|143-150

ISSN： 1388-9842

Source： EUROPEAN JOURNAL OF HEART FAILURE, Vol.16, Iss.2, 2014-02, pp. : 143-150

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study‐Heart Failure (ARTS‐HF): a randomized study of finerenone vs. eplerenone in patients who have worsening chronic heart failure with diabetes and/or chronic kidney disease

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 2, 2015-02 ,pp. : 224-232

John Wiley & Sons Inc

Access to resources Recommend Favorite

Management of hypertension and heart failure in patients with Addison's disease

By  

CLINICAL ENDOCRINOLOGY, Vol. 82, Iss. 6, 2015-06 ,pp. : 789-792

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of the Galanin Receptor Antagonist M40 on Cardiac Function and Remodeling in Rats with Heart Failure

By  

CARDIOVASCULAR THERAPEUTICS (ELECTRONIC), Vol. 33, Iss. 5, 2015-10 ,pp. : 288-293

John Wiley & Sons Inc

Access to resources Recommend Favorite

Progression from Hypertension to Heart Failure

By  

Cardiology, Vol. 92, Iss. 1, 1999-12 ,pp. : 10-19

Karger

Access to resources Recommend Favorite

Hemodynamic and Hormonal Effects of the Angiotensin II Antagonist, Candesartan Cilexetil, in Patients with Congestive Heart Failure

By  

Cardiology, Vol. 93, Iss. 3, 2000-08 ,pp. : 175-182

Karger

Access to resources Recommend Favorite